theme 2: target identification and validation Flashcards

1
Q

give 4 examples of screening technologies

A

FLIPR- ca2+, nanoBRET, Reporter genes, label free

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what is FLIPR screening

A

this is a functional signalling assay for GPCRs. it measures intracellular calcium levels within intact cells.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what is a BRET (bioluminescence resonance energy transfer) assay

A

a flourescent tag is added to the N-terminus of the receptor called NanoLuciferase. When a substrate binds to the receptor, the energy transfer means a blue light is given off of by the NanoLuciferase. This shows the expression of receptors.
Activation by a particular ligand can be measured using a flourecent labelled ligand. When this binds to the receptor the energy given off by the nano luciferase can excite the fluorophore on the flourecent labelled ligand and cause another colour signal to be given off alongside the blue nanoluciferase. This shows whether the receptor activation occurs by the flourecent labelled ligand or other non-labelled ligand.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

how are reporter genes used in screening

A

Essentially, it measures the production of proteins by the expression of fourescence.
When the fluorescently labelled ligand is activated and excited, a colour is given off
Fluorescent labels can be encoded into cells downstream of a promotor region in a gene that detects a particular signal, such as an increase in Camp within the cell caused by gene expression.
The expression of the fluorescent label can then be measured as a measure of gene expression.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what are label free technoligies

A

this measures chnages in local refractive index resulting from the ligand induced mass redistribution (change in configurement of cell organelles) in the bottom region of the cell monolayer. It is manifested as a shift in resonant wavelength.

ie the redistribution of organelles changes the reflected wavelength given off when the broadband source is directed at the bottom of the cell.
ligand binding can change the distribution of organelles.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

list the order of processes in molecular target screening

A
  • disease selection
  • target identification
  • assay development
  • hit to lead
  • lead optimisation
    -preclinical development
  • clinical trials
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

list the processes involved in phenotypic screening

A
  • disease selection
  • assay development
  • hit to lead
  • target identification
  • lead optimisation
    -preclinical development
  • clinical trials
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what is the difference between molecular target and phenotypic screening?

A

in molecular target screening. a novel genetically encoded target is chosen and drigs that interacted with it are identified. diseases where this may have application are then found.
In phenotypic screening, a disease phenotype is first found. drugs used here are then found and then specific protein targets are identified

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

in what screening type is the molecular target of the disease to be known

A

molecular target screening

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what is the method of lead conformation in molecular target screening?

A

a direct binding assay is used or x-ray, crystallography
lead conformation needs to take place in cell based and phenotypic assays

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

give an example of a primary cell type used in phenotypic screens

A

thyrocytes
bronchial epithelial cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what does IPS stand for

A

induced pluripotent stem cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

give four examples of IPS cells

A

neurons, cardiomyocytes, hepatocytes, endothelial cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what does the orexin system play a key role in

A

wakefullness. narcoeleptic patients have very few orexin producing neurons

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

define allosteric modulator

A

molecule imposng allosteric change on gpcr

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

define orthosteric ligand

A

Molecule binding to the same site as the endogenous ligand that senses the altered receptor site

17
Q

define biased signalling

A

Different ligands can stabilise specific conformations of the receptor that favour coupling to the g protein or g protein independent signalling proteins

18
Q

define homodimer

A

Dimerisation with an identical receptor - can lead to cooperativity or signalling bias

19
Q

define heterodimer

A

dimerisation with different receptor - biased signalling and cooperativity

20
Q

define an orphan receptor

A

An orphan receptor is a protein that has a similar structure to other identified receptors but whose endogenous ligand has not yet been identified.

21
Q

how are orphan receptors used in GPCR target identification

A

knowing the stricture and some drugs that target it can help to identrify endogenpous liogands and therefore drug develpment starting from the endogenous ligand can take placem

22
Q

how can viruses lead to cancer

A

viruses infect cells by encoding their DNA into the host so proteins can be made. One of these proteins may be a GPCR that responds to endogenous chemokines that when bound to and activated, can induce transcription and cell growth and replication. if this occurs uncontrollably, a tumour can develop ie cancer

23
Q

give an example of a receptor tyrosine kinase

A

HER2 human epidermal growth factor receptor 2
EGFR
HER4
HER3

24
Q

What is HER2

A

a tyrosine kinase receptor that is amplified in some breast cancer cases and other cancers. it is targetted by antobodies and some drugs includig trastuzumab, pertuzumab, lapatinib

25
Q
A